PINE

Main information

  • Trade name:
  • PINE O CLEEN GLEN 20 SURFACE SPRAY DISINFECTANT - HOSPITAL GRADE - Garden
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • PINE O CLEEN GLEN 20 SURFACE SPRAY DISINFECTANT - HOSPITAL GRADE - Garden
    Australia
  • Language:
  • English

Other information

Status

  • Source:
  • Dept. of Health,Therapeutic Goods Administration - Australia
  • Authorization number:
  • 208254
  • Last update:
  • 10-10-2017

Public Assessment Report

Public Summary

Summary for ARTG Entry:

208254

Reckitt Benckiser Pty Ltd - PINE O CLEEN GLEN 20 SURFACE SPRAY DISINFECTANT HOSPITAL

GRADE,WITH CLAIMS, NON-STERILE.

ARTG entry for

Other Therapeutic Good - Registered disinfectant

Sponsor

Reckitt Benckiser Pty Ltd

Postal Address

PO Box 20097 World Square,Sydney, NSW, 2002

Australia

ARTG Start Date

17/04/2013

Product category

Other Therapeutic Good

Status

Active

Approval area

Medical Devices

Conditions

Conditions applicable to all therapeutic goods as specified in the document "Standard Conditions Applying to Registered or Listed Therapeutic Goods

Under Section 28 of the Therapeutic Goods Act 1989" effective 1 July 1995.

Conditions applicable to the relevant category and class of therapeutic goods as specified in the document "Standard Conditions Applying to Registered

or Listed Therapeutic Goods Under Section 28 of the Therapeutic Goods Act 1989" effective 1 July 1995.

Conditions applicable to the relevant category and class of therapeutic devices as specified in the document 'Conditions on Registration or Listing

Applying to Specific Groups of Therapeutic Devices under Section 28 of the Therapeutic Goods Act 1989' effective 23 April 1998.

Products

1. PINE O CLEEN GLEN 20 SURFACE SPRAY DISINFECTANT - HOSPITAL GRADE - Original Scent

Product Type

Single Device Product

Effective date

24/04/2013

GMDN

9950 Disinfectant, hospital grade

Intended purpose

Surface Spray Disinfectant - Hospital Grade with specific claims

Specific Conditions

No Specific Conditions included on Record

2. PINE O CLEEN GLEN 20 SURFACE SPRAY DISINFECTANT - HOSPITAL GRADE - Mountain Air

Product Type

Single Device Product

Effective date

24/04/2013

GMDN

9950 Disinfectant, hospital grade

Intended purpose

Surface Spray Disinfectant - Hospital Grade with specific claims

Specific Conditions

No Specific Conditions included on Record

3. PINE O CLEEN GLEN 20 SURFACE SPRAY DISINFECTANT - HOSPITAL GRADE - Fresh Scent

Product Type

Single Device Product

Effective date

24/04/2013

GMDN

9950 Disinfectant, hospital grade

Intended purpose

Surface Spray Disinfectant - Hospital Grade with specific claims

Specific Conditions

No Specific Conditions included on Record

4. PINE O CLEEN GLEN 20 SURFACE SPRAY DISINFECTANT - HOSPITAL GRADE - Spring Fragrance

Product Type

Single Device Product

Effective date

24/04/2013

GMDN

9950 Disinfectant, hospital grade

Intended purpose

Surface Spray Disinfectant - Hospital Grade with specific claims

Specific Conditions

No Specific Conditions included on Record

5. PINE O CLEEN GLEN 20 SURFACE SPRAY DISINFECTANT - HOSPITAL GRADE - Lavender

Product Type

Single Device Product

Effective date

24/04/2013

GMDN

9950 Disinfectant, hospital grade

Intended purpose

Surface Spray Disinfectant - Hospital Grade with specific claims

Specific Conditions

Public Summary

Page 1 of

Produced at 22.11.2017 at 02:26:35 AEDT

This is not an ARTG Certificate document.

The onus is on the reader to verify the current accuracy of the information on the document subsequent to the date shown.

Visit www.tga.gov.au for contact information

No Specific Conditions included on Record

6. PINE O CLEEN GLEN 20 SURFACE SPRAY DISINFECTANT - HOSPITAL GRADE - Morning

Product Type

Single Device Product

Effective date

24/04/2013

GMDN

9950 Disinfectant, hospital grade

Intended purpose

Surface Spray Disinfectant - Hospital Grade with specific claims

Specific Conditions

No Specific Conditions included on Record

7. PINE O CLEEN GLEN 20 SURFACE SPRAY DISINFECTANT - HOSPITAL GRADE - Garden

Product Type

Single Device Product

Effective date

24/04/2013

GMDN

9950 Disinfectant, hospital grade

Intended purpose

Surface Spray Disinfectant - Hospital Grade with specific claims

Specific Conditions

No Specific Conditions included on Record

8. PINE O CLEEN GLEN 20 SURFACE SPRAY DISINFECTANT - HOSPITAL GRADE - Country Scent

Product Type

Single Device Product

Effective date

24/04/2013

GMDN

9950 Disinfectant, hospital grade

Intended purpose

Surface Spray Disinfectant - Hospital Grade with specific claims

Specific Conditions

No Specific Conditions included on Record

9. PINE O CLEEN GLEN 20 SURFACE SPRAY DISINFECTANT - HOSPITAL GRADE - Crisp Linen

Product Type

Single Device Product

Effective date

24/04/2013

GMDN

9950 Disinfectant, hospital grade

Intended purpose

Surface Spray Disinfectant - Hospital Grade with specific claims

Specific Conditions

No Specific Conditions included on Record

10. PINE O CLEEN GLEN 20 SURFACE SPRAY DISINFECTANT - HOSPITAL GRADE - Citrus

Product Type

Single Device Product

Effective date

24/04/2013

GMDN

9950 Disinfectant, hospital grade

Intended purpose

Surface Spray Disinfectant - Hospital Grade with specific claims

Specific Conditions

No Specific Conditions included on Record

© Commonwealth of Australia.This work is copyright.You are not permitted to re-transmit, distribute or commercialise the material without obtaining prior

written approval from the Commonwealth.Further details can be found at http://www.tga.gov.au/about/website-copyright.htm.

Public Summary

Page 2 of

Produced at 22.11.2017 at 02:26:35 AEDT

This is not an ARTG Certificate document.

The onus is on the reader to verify the current accuracy of the information on the document subsequent to the date shown.

Visit www.tga.gov.au for contact information

20-11-2018

Pest categorisation of non‐EU Monochamus spp.

Pest categorisation of non‐EU Monochamus spp.

Published on: Mon, 19 Nov 2018 The Panel on Plant Health performed a pest categorisation of non‐EU Monochamus spp., a well‐defined insect genus in the family Cerambycidae (Insecta: Coleoptera). Species can be identified using taxonomic keys at national and regional level, and DNA barcoding. Two online world catalogues exist for the genus. The genus includes about one hundred species and many subspecies colonising conifers and non‐conifer trees in many areas in the world. The non‐EU species are listed in...

Europe - EFSA - European Food Safety Authority Publications

20-11-2018

Modification of the existing maximum residue levels and setting of import tolerances for pyraclostrobin in various crops

Modification of the existing maximum residue levels and setting of import tolerances for pyraclostrobin in various crops

Published on: Mon, 19 Nov 2018 In accordance with Article 6 of Regulation (EC) No 396/2005, the applicant BASF SE submitted two requests to the competent national authority in Germany. The first one, to modify the existing maximum residue levels (MRL) for the active substance pyraclostrobin in various crops and to set import tolerances for sugar canes and American persimmons; the second one to set import tolerances for pineapples and passion fruits/maracujas. The data submitted in support of the request...

Europe - EFSA - European Food Safety Authority Publications

16-10-2018

Pest categorisation of Cronartium harknessii, Cronartium kurilense and Cronartium sahoanum

Pest categorisation of Cronartium harknessii, Cronartium kurilense and Cronartium sahoanum

Published on: Mon, 15 Oct 2018 00:00:00 +0200 Following a request from the European Commission, the EFSA Panel on Plant Health performed a pest categorisation of Cronartium harknessii, Cronartium kurilense and Cronartium sahoanum, which are well‐defined and distinguishable tree fungal pathogens of the family Cronartiaceae. In 2018, these species were moved from the genus Endocronartium to the genus Cronartium. These pathogens are not known to be present in the EU and are regulated in Council Directive 2...

Europe - EFSA - European Food Safety Authority Publications

21-9-2018

FDA Animal Drug Safety Communication: FDA Reminds Veterinarians of the Differences Between Approved and Compounded Formulas of Transdermal Mirtazapine for the Management of Weight Loss in Cats

FDA Animal Drug Safety Communication: FDA Reminds Veterinarians of the Differences Between Approved and Compounded Formulas of Transdermal Mirtazapine for the Management of Weight Loss in Cats

CVM Update describing FDA Dear Veterinarian Letter about the differences between FDA-approved Mirataz (mirtazapine transdermal ointment), an animal drug with demonstrated safety and effectiveness to manage undesired weight loss in cats, and compounded formulations of transdermal mirtazapine.

FDA - U.S. Food and Drug Administration

29-6-2018

Medicines Safety Update, Volume 9, Number 2, June 2018

Medicines Safety Update, Volume 9, Number 2, June 2018

Oral methotrexate dosing, medicines associated with a risk of neuropsychiatric adverse events, and clozapine and gastrointestinal effects

Therapeutic Goods Administration - Australia

23-5-2018

FDA Drug Safety Communication: FDA to evaluate potential risk of neural tube birth defects with HIV medicine dolutegravir (Juluca, Tivicay, Triumeq)

FDA Drug Safety Communication: FDA to evaluate potential risk of neural tube birth defects with HIV medicine dolutegravir (Juluca, Tivicay, Triumeq)

The U.S. Food and Drug Administration (FDA) is alerting the public that serious cases of neural tube birth defects involving the brain, spine, and spinal cord have been reported in babies born to women treated with dolutegravir (Juluca, Tivicay, Triumeq) used to treat human immunodeficiency virus (HIV).

FDA - U.S. Food and Drug Administration

14-5-2018

FDA Approves Mirataz, a New Animal Drug to Manage Undesired Weight Loss in Cats

FDA Approves Mirataz, a New Animal Drug to Manage Undesired Weight Loss in Cats

FDA has approved Mirataz (mirtazapine transdermal ointment), a new animal drug to manage undesired weight loss in cats. Mirataz is the first transdermal product to receive FDA approval for use in cats. FDA-approved drugs have been demonstrated to be safe and effective for their intended use.

FDA - U.S. Food and Drug Administration

31-10-2018

Viramune (Boehringer Ingelheim International GmbH)

Viramune (Boehringer Ingelheim International GmbH)

Viramune (Active substance: nevirapine) - Centralised - Yearly update - Commission Decision (2018)7337 of Wed, 31 Oct 2018

Europe -DG Health and Food Safety